
Title: Study Director; Developmental and Reproductive Toxicology (DART)
Location: Chicago, IL (on-site)
Reporting to: VP of Toxicology
Frontage Laboratories Inc. is an award winning, full-service, CRO/Contract Research Organization operating over 25 state-of-the-art laboratories across the US, Canada and China. Our core competencies include drug metabolism, pharmacokinetics/ pharmacodynamics (PK/PD), safety and toxicology, bioanalytical services, chemistry and manufacturing controls for drug development, and core laboratory services for clinical trials.
Our Chicago, IL site provides toxicology testing and research laboratory services and specialized pre‑clinical studies in support of pharmaceutical and biotechnology products.
We have an excellent career opportunity for a Study Director – Developmental and Reproductive Toxicology (DART) to join our dynamic team in Chicago!
Position/Job Summary: This position is for a Study Director within the Developmental and Reproductive Toxicology (DART) department at Frontage, specifically to perform duties related to directing nonclinical Developmental and Reproductive Toxicology (DART) studies as Study Director for regulatory submissions. The person will serve as the DART Study Director for Developmental and Reproductive Toxicology Studies, including Embryo-fetal Development, Fertility, Pre-/Postnatal and Juvenile Toxicology Studies as described in the GLPs. They have overall responsibility for the technical conduct of a study as well as for the interpretation, analysis, documentation, and reporting of results. Activities also include productive interactions with management, technical staff, global internal and external clients, and study direction staff.
Salary: $95K-$130K, negotiable based on qualification and experience
Frontage Laboratories Inc. is an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, religion, color, national origin, sex, sexual orientation, gender identity, age, status as a protected veteran, among other things, or status as a qualified individual with disability.

Frontage Laboratories is a US-based Contract Research Organization (CRO) that was initially established in New Jersey in April 2001 and later relocated to Pennsylvania in 2004. As an FDA-registered and inspected global pharmaceutical development and manufacturing organization, Frontage is headquartered in Exton, PA, with a state-of-the-art 26 facilities spread across Pennsylvania, New Jersey, Illinois, Ohio, California, Florida, Canada, Italy, and China. We are dedicated to accelerating the development of innovative therapies by providing a broad range of science-driven and quality-focused services including drug discovery, DMPK, preclinical safety & toxicology, formulation development and manufacturing, analytical, clinical trials, bioanalytical, and central labs. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of molecules through development and file regulatory submissions in the US, EU, China, and other countries.